- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/20 - Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
Patent holdings for IPC class C07D 217/20
Total number of patents in this class: 85
10-year publication summary
5
|
3
|
0
|
2
|
3
|
3
|
4
|
7
|
4
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Mallinckrodt LLC | 133 |
11 |
SpecGx LLC | 196 |
8 |
Chemagis Ltd. | 33 |
4 |
Dermavant Sciences GmbH | 79 |
4 |
Bausch + Lomb Ireland Limited | 682 |
4 |
Mallinckrodt Inc. | 193 |
3 |
Takeda Pharmaceutical Company Limited | 2945 |
2 |
Academia Sinica | 918 |
2 |
Albany Molecular Research, Inc. | 64 |
2 |
Analytecon SA | 2 |
2 |
City of Hope | 963 |
2 |
Cornell University | 3215 |
2 |
Recordati Industria Chimica e Farmaceutica S.p.A. | 56 |
2 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 806 |
2 |
Taipei Medical University | 178 |
2 |
Taisho Pharmaceutical Co., Ltd. | 854 |
2 |
Idorsia Pharmaceuticals Ltd. | 364 |
2 |
Novartis Pharmaceuticals Corporation | 52 |
1 |
The Regents of the University of California | 19572 |
1 |
University of Florida Research Foundation, Inc. | 3965 |
1 |
Other owners | 26 |